Skip to content

comparison the effect of DNS exercise with and without the use of VR on Hyperlordosis with nonspecific chronic low back pain

Comparison of the Effect of six Weeks of Dynamic Neuromuscular Stabilization (DNS) Exercise with and without the Use of Virtual Reality (VR) on pain, Balance, Proprioception, Range of Motion and Lumbar Arch Degree in Middle-aged Women with Hyperlordosis with nonspecific chronic low back pain: A randomized clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250801066719N1
Enrollment
50
Registered
2025-08-19
Start date
2025-08-25
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

????????????? ????? ?? ?????? ???? ??????????. Low back pain

Interventions

Intervention 1: Intervention group 1: The group receiving dynamic neuromuscular training combined with virtual reality technology. Participants receive Dynamic Neuromuscular Stabilization exercises co
the chosen VR game (Dodgeball) is selected based on prior literature for this population. Intervention 2: Intervention group 2:The group receiving dynamic neuromuscular training without the use of vir

Sponsors

The University of Shahid Beheshti
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
30 Years to 50 Years

Inclusion criteria

Inclusion criteria: Women between 30-50 years of age Lumbar lordosis greater than 40 degrees Body-mass index (BMI) between 18.5 and 27 Pain intensity between 3 and 7 on the Visual Analogue Scale (VAS)

Exclusion criteria

Exclusion criteria: history of spinal fractures, surgery, or joint disease Use of orthotic insoles, a cane, antidepressant or narcotic medications, or muscle relaxants within 30 days prior to the study, and no significant visual impairment or motor disorders that would prevent the use of virtual-reality equipment Presence of pathological signs related to the condition, such as heart disease, cancer, tumors, previous surgery, etc. Presence of orthopedic deformities or neurosurgical diseases Presence of disc degeneration or other conditions that could influence the interpretation of the results (e.g., severe fibromyalgia or rheumatoid arthritis in combination with other treatments) Surgery or pregnancy within the past 30 days Use of devices or apparatuses for treating hyper-lordosis Presence of any other postural abnormalities

Design outcomes

Primary

MeasureTime frame
Hyperlordosis. Timepoint: Outcome assessments will be conducted at baseline and after the completion of the 6-week intervention period. Method of measurement: Hyperlordosis will be assessed using the Spinal Mouse device.;Pain intensity. Timepoint: Outcome assessment will be conducted at baseline and after the completion of the 6-week intervention period. Method of measurement: Pain intensity will be measured using the Visual Analogue.

Secondary

MeasureTime frame
Static balance. Timepoint: Outcome assessment will be conducted at baseline and after the completion of the 6-week intervention period. Method of measurement: static Balance will be assessed using the Biodex Balance System.;Dynamic balance. Timepoint: Outcome assessment will be conducted at baseline and after the completion of the 6-week intervention period. Method of measurement: Dynamic Balance will be assessed using the Biodex Balance System.;Lumbar proprioception. Timepoint: Outcome assessment will be conducted at baseline and after the completion of the 6-week intervention period. Method of measurement: Lumbar Proprioception will be measured using a goniometer.;Range of motion. Timepoint: Outcome assessment will be conducted at baseline and after the completion of the 6-week intervention period. Method of measurement: Range of motion will be measured using the MobeeMed device.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNiusha Tashakori

The University of Shahid Beheshti

Nta.1379.nt@gmail.com+98 21 4409 5051

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026